Study analysis · Scientific Reports · 2026
This vitamin combo slashed fatigue in UC patients—but did NOTHING for Crohn’s disease.
Taking B vitamins and magnesium for 4 weeks made people with ulcerative colitis feel less tired and less symptomatic, but didn’t help those with Crohn’s disease or their overall quality of life.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study gave some people vitamins and magnesium and others fake pills, then asked them how tired they felt and how their stomach felt. The people who got the real vitamins said they felt less tired and had fewer stomach symptoms — but we don’t know if it’s because the vitamins fixed something inside their body or just because they felt better thinking they were getting help.
What’s the bottom line?
Scientists gave IBD patients who felt tired a daily pill with B vitamins and magnesium to see if it helped them feel better.
How strong is this study?
This study was pretty well done because nobody knew who got the real vitamins or the fake ones, and they used a fair way to pick who got what. But it’s not perfect — they didn’t check if people were low on vitamins to begin with, and they only watched them for 4 weeks, so we can’t be totally sure the results will last.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
85 / 100
- Randomization+20/20
- Blinding+15/15
- Control group+15/15
- Sample size (n=98)+7.8/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 583 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. The study is a randomized controlled trial with blinding and a control group, which allows for causal inference. However, the lack of objective biomarkers (e.g., CRP, calprotectin) and unmeasured baseline micronutrient levels limits confidence that observed effects are due to direct biological causation rather than unmeasured confounders or placebo effects.
Moderate COI
Moderate conflicts that may influence study outcomes
The study was not explicitly funded by any external source, but the supplements were manufactured by two private companies (Mahban Darou Co and Jalinus Co), and authors may have had indirect industry ties through product sourcing, raising potential bias in intervention selection and interpretation.
Conflict Details
Mahban Darou Co: Supplied vitamin B1, B6, and B12 tablets used in the intervention
Jalinus Co: Supplied magnesium oxide tablets used in the intervention
Independent Analysis Safeguards
- Block randomization performed by an independent statistician at Iran University of Medical Sciences
- Blinded study coordinator labeled and packaged supplements and placebo
- Both participants and investigators were blinded to group allocation
Although no direct funding or employment ties are disclosed, the use of specific commercial products without independent verification of formulation or quality control introduces potential bias. The lack of a formal funding statement or COI declaration reduces transparency. The study's single-center design and lack of independent data analysis oversight beyond randomization further limit confidence in objectivity.
Key takeaways
- 01
In ulcerative colitis patients: fatigue dropped by 1.98 points (out of 20) and disease symptoms dropped by 1.32 points.
- 02
In Crohn’s disease patients: no change.
- 03
Quality of life didn’t improve.
- 04
The fatigue and symptom improvements were real and statistically strong in UC patients, but not big enough to improve overall life quality in just 4 weeks.
Surprising findings
- B vitamins and magnesium improved UC symptoms but had zero effect on Crohn’s disease, even though both are IBD.Most people assume IBD is one condition with similar treatments—this study shows biology differs drastically between UC and Crohn’s, even in remission.
- Fatigue improved significantly, but quality of life didn’t—despite the same intervention.We assume reducing fatigue should automatically improve life satisfaction—but this study proves they’re not linked in the short term.
Practical takeaways
If you have ulcerative colitis in remission and still feel fatigued, consider talking to your doctor about trying a B1/B6/B12/magnesium supplement for 4–6 weeks.
This study didn’t test if you’re deficient, and it didn’t improve quality of life—so don’t expect life-changing results. Also, it didn’t work for Crohn’s disease.
medium confidenceWhy this study matters
UC vs. Crohn’s: A Split Response
In ulcerative colitis patients, daily supplementation with B1, B6, B12, and magnesium reduced fatigue by 1.98 points (out of 20) on the IBD-F scale (p<0.001) and cut disease activity by 1.32 points on the P-SCCAI (p=0.006). But in Crohn’s disease patients, there was no significant change in SCDAI scores (β = −3.93, p=0.301), despite identical dosing.
People assume all IBD is the same—but this shows the body responds differently to the same treatment based on disease type, which could reshape how we personalize nutrition for chronic illness.
Fatigue Dropped—But Quality of Life Didn’t
Despite significant drops in fatigue and symptom scores, health-related quality of life (IBDQ-9) didn’t improve (β = 1.21, p=0.114). Even though patients felt less tired, their overall sense of well-being stayed the same after 4 weeks.
It’s counterintuitive: you fix symptoms and fatigue, but still don’t feel better in life. This suggests fatigue and quality of life are driven by different factors—maybe mental health or social isolation.
No Blood Tests? No Clue Why It Worked
The study didn’t measure baseline or post-intervention levels of B vitamins or magnesium—so they don’t know if participants were deficient. The benefit might come from correcting deficiency… or from a pharmacological effect.
Most people think supplements only help if you’re deficient—but this study hints they might work even without deficiency, which could change how we think about daily vitamins.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists gave IBD patients who felt tired a daily pill with B vitamins and magnesium to see if it helped them feel better.
Research results
In ulcerative colitis patients: fatigue dropped by 1.98 points (out of 20) and disease symptoms dropped by 1.32 points. In Crohn’s disease patients: no change. Quality of life didn’t improve.
What this means - more context
The fatigue and symptom improvements were real and statistically strong in UC patients, but not big enough to improve overall life quality in just 4 weeks.
This study tested whether daily supplementation with B vitamins (B1, B6, B12) and magnesium improves fatigue, disease activity, and quality of life in adults with inflammatory bowel disease (IBD) in remission.
In a 4-week randomized, double-blind, placebo-controlled trial of 98 adults with IBD in remission, supplementation significantly reduced fatigue and patient-reported disease activity in ulcerative colitis (UC), but showed no significant effect on Crohn’s disease activity or health-related quality of life.
Methods Used
98 adults with IBD in remission were randomized 1:1 to receive daily oral supplementation of 100 mg vitamin B1, 100 mg vitamin B6, 200 µg vitamin B12, and 250 mg magnesium, or placebo, for 4 weeks. Outcomes were measured using validated patient-reported scales (IBD-F, P-SCCAI, SCDAI, IBDQ-9) in a double-blind design with adjustment for baseline medication use.
Main Finding
Supplementation significantly reduced fatigue (IBD-F Section 1: β = −1.98, p<0.001; Section 2: β = −5.19, p<0.001) and UC disease activity (P-SCCAI: β = −1.32, p=0.006), but had no significant effect on Crohn’s disease activity (SCDAI: β = −3.93, p=0.301) or quality of life (IBDQ-9: β = 1.21, p=0.114).
Confidence Level
Moderate — study is a well-conducted RCT with blinding, randomization, and adjustment for confounders, but limited by small subgroup sizes (especially Crohn’s disease), lack of biomarker data, and short duration.
Study Flags
Red Flags
- •Subgroup sample sizes too small for reliable Crohn’s disease conclusions
- •No baseline or post-intervention serum micronutrient levels measured
- •Short 4-week duration may not capture long-term effects on quality of life
Surprising Findings
B vitamins and magnesium improved UC symptoms but had zero effect on Crohn’s disease, even though both are IBD.
Most people assume IBD is one condition with similar treatments—this study shows biology differs drastically between UC and Crohn’s, even in remission.
Practical Takeaways
If you have ulcerative colitis in remission and still feel fatigued, consider talking to your doctor about trying a B1/B6/B12/magnesium supplement for 4–6 weeks.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 583 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
This study gave some people vitamins and magnesium and others fake pills, then asked them how tired they felt and how their stomach felt. The people who got the real vitamins said they felt less tired and had fewer stomach symptoms — but we don’t know if it’s because the vitamins fixed something inside their body or just because they felt better thinking they were getting help.
Moderate conflicts detected — such as industry funding with partial involvement. A meaningful penalty has been applied.
Strengths
- Randomized, double-blind, placebo-controlled design
- Use of validated patient-reported outcome measures
- A priori sample size calculation with power analysis
Weaknesses
- No measurement of baseline or post-intervention serum micronutrient levels
- No objective inflammatory biomarkers (e.g., CRP, calprotectin) to confirm biological mechanism
- Underpowered for subgroup analyses (especially Crohn’s disease)
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists gave IBD patients who felt tired a daily pill with B vitamins and magnesium to see if it helped them feel better.
Research results
In ulcerative colitis patients: fatigue dropped by 1.98 points (out of 20) and disease symptoms dropped by 1.32 points. In Crohn’s disease patients: no change. Quality of life didn’t improve.
What this means - more context
The fatigue and symptom improvements were real and statistically strong in UC patients, but not big enough to improve overall life quality in just 4 weeks.
This study tested whether daily supplementation with B vitamins (B1, B6, B12) and magnesium improves fatigue, disease activity, and quality of life in adults with inflammatory bowel disease (IBD) in remission.
In a 4-week randomized, double-blind, placebo-controlled trial of 98 adults with IBD in remission, supplementation significantly reduced fatigue and patient-reported disease activity in ulcerative colitis (UC), but showed no significant effect on Crohn’s disease activity or health-related quality of life.
Methods Used
98 adults with IBD in remission were randomized 1:1 to receive daily oral supplementation of 100 mg vitamin B1, 100 mg vitamin B6, 200 µg vitamin B12, and 250 mg magnesium, or placebo, for 4 weeks. Outcomes were measured using validated patient-reported scales (IBD-F, P-SCCAI, SCDAI, IBDQ-9) in a double-blind design with adjustment for baseline medication use.
Main Finding
Supplementation significantly reduced fatigue (IBD-F Section 1: β = −1.98, p<0.001; Section 2: β = −5.19, p<0.001) and UC disease activity (P-SCCAI: β = −1.32, p=0.006), but had no significant effect on Crohn’s disease activity (SCDAI: β = −3.93, p=0.301) or quality of life (IBDQ-9: β = 1.21, p=0.114).
Confidence Level
Moderate — study is a well-conducted RCT with blinding, randomization, and adjustment for confounders, but limited by small subgroup sizes (especially Crohn’s disease), lack of biomarker data, and short duration.
Study Flags
Red Flags
- •Subgroup sample sizes too small for reliable Crohn’s disease conclusions
- •No baseline or post-intervention serum micronutrient levels measured
- •Short 4-week duration may not capture long-term effects on quality of life
Surprising Findings
B vitamins and magnesium improved UC symptoms but had zero effect on Crohn’s disease, even though both are IBD.
Most people assume IBD is one condition with similar treatments—this study shows biology differs drastically between UC and Crohn’s, even in remission.
Practical Takeaways
If you have ulcerative colitis in remission and still feel fatigued, consider talking to your doctor about trying a B1/B6/B12/magnesium supplement for 4–6 weeks.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 583 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
This study gave some people vitamins and magnesium and others fake pills, then asked them how tired they felt and how their stomach felt. The people who got the real vitamins said they felt less tired and had fewer stomach symptoms — but we don’t know if it’s because the vitamins fixed something inside their body or just because they felt better thinking they were getting help.
Moderate conflicts detected — such as industry funding with partial involvement. A meaningful penalty has been applied.
Strengths
- Randomized, double-blind, placebo-controlled design
- Use of validated patient-reported outcome measures
- A priori sample size calculation with power analysis
Weaknesses
- No measurement of baseline or post-intervention serum micronutrient levels
- No objective inflammatory biomarkers (e.g., CRP, calprotectin) to confirm biological mechanism
- Underpowered for subgroup analyses (especially Crohn’s disease)
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study was pretty well done because nobody knew who got the real vitamins or the fake ones, and they used a fair way to pick who got what. But it’s not perfect — they didn’t check if people were low on vitamins to begin with, and they only watched them for 4 weeks, so we can’t be totally sure the results will last.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
85 / 100
- Randomization+20/20
- Blinding+15/15
- Control group+15/15
- Sample size (n=98)+7.8/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 583 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. The study is a randomized controlled trial with blinding and a control group, which allows for causal inference. However, the lack of objective biomarkers (e.g., CRP, calprotectin) and unmeasured baseline micronutrient levels limits confidence that observed effects are due to direct biological causation rather than unmeasured confounders or placebo effects.
Moderate COI
Moderate conflicts that may influence study outcomes
The study was not explicitly funded by any external source, but the supplements were manufactured by two private companies (Mahban Darou Co and Jalinus Co), and authors may have had indirect industry ties through product sourcing, raising potential bias in intervention selection and interpretation.
Conflict Details
Mahban Darou Co: Supplied vitamin B1, B6, and B12 tablets used in the intervention
Jalinus Co: Supplied magnesium oxide tablets used in the intervention
Independent Analysis Safeguards
- Block randomization performed by an independent statistician at Iran University of Medical Sciences
- Blinded study coordinator labeled and packaged supplements and placebo
- Both participants and investigators were blinded to group allocation
Although no direct funding or employment ties are disclosed, the use of specific commercial products without independent verification of formulation or quality control introduces potential bias. The lack of a formal funding statement or COI declaration reduces transparency. The study's single-center design and lack of independent data analysis oversight beyond randomization further limit confidence in objectivity.